279 related articles for article (PubMed ID: 32135248)
1. A machine learning-driven study indicates emodin improves cardiac hypertrophy by modulation of mitochondrial SIRT3 signaling.
Gao J; Zhang K; Wang Y; Guo R; Liu H; Jia C; Sun X; Wu C; Wang W; Du J; Chen J
Pharmacol Res; 2020 May; 155():104739. PubMed ID: 32135248
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-214 contributes to Ang II-induced cardiac hypertrophy by targeting SIRT3 to provoke mitochondrial malfunction.
Ding YQ; Zhang YH; Lu J; Li B; Yu WJ; Yue ZB; Hu YH; Wang PX; Li JY; Cai SD; Ye JT; Liu PQ
Acta Pharmacol Sin; 2021 Sep; 42(9):1422-1436. PubMed ID: 33247214
[TBL] [Abstract][Full Text] [Related]
3. Exogenous NADPH exerts a positive inotropic effect and enhances energy metabolism via SIRT3 in pathological cardiac hypertrophy and heart failure.
Qian K; Tang J; Ling YJ; Zhou M; Yan XX; Xie Y; Zhu LJ; Nirmala K; Sun KY; Qin ZH; Sheng R
EBioMedicine; 2023 Dec; 98():104863. PubMed ID: 37950995
[TBL] [Abstract][Full Text] [Related]
4. 2-APQC, a small-molecule activator of Sirtuin-3 (SIRT3), alleviates myocardial hypertrophy and fibrosis by regulating mitochondrial homeostasis.
Peng F; Liao M; Jin W; Liu W; Li Z; Fan Z; Zou L; Chen S; Zhu L; Zhao Q; Zhan G; Ouyang L; Peng C; Han B; Zhang J; Fu L
Signal Transduct Target Ther; 2024 May; 9(1):133. PubMed ID: 38744811
[TBL] [Abstract][Full Text] [Related]
5. SIRT3 regulates cardiolipin biosynthesis in pressure overload-induced cardiac remodeling by PPARγ-mediated mechanism.
Liu LX; Zheng XH; Hai JH; Zhang CM; Ti Y; Chen TS; Bu PL
PLoS One; 2024; 19(4):e0301990. PubMed ID: 38625851
[TBL] [Abstract][Full Text] [Related]
6. Gastrodin alleviates mitochondrial dysfunction by regulating SIRT3-mediated TFAM acetylation in vascular dementia.
Chen YX; Yang H; Wang DS; Chen TT; Qi XL; Tao L; Chen Y; Shen XC
Phytomedicine; 2024 Jun; 128():155369. PubMed ID: 38547618
[TBL] [Abstract][Full Text] [Related]
7. Cyclovirobuxine D alleviates aldosterone-induced myocardial hypertrophy by protecting mitochondrial function depending on the mutual regulation of Nrf2-SIRT3.
Wang X; Wu H; An J; Zhang G; Chen Y; Fu L; Tao L; Liang G; Shen X
Biomed Pharmacother; 2023 Nov; 167():115618. PubMed ID: 37793277
[TBL] [Abstract][Full Text] [Related]
8. SZC-6, a small-molecule activator of SIRT3, attenuates cardiac hypertrophy in mice.
Li ZY; Lu GQ; Lu J; Wang PX; Zhang XL; Zou Y; Liu PQ
Acta Pharmacol Sin; 2023 Mar; 44(3):546-560. PubMed ID: 36042291
[TBL] [Abstract][Full Text] [Related]
9. Dihydromyricetin Attenuates Myocardial Hypertrophy Induced by Transverse Aortic Constriction via Oxidative Stress Inhibition and SIRT3 Pathway Enhancement.
Chen Y; Luo HQ; Sun LL; Xu MT; Yu J; Liu LL; Zhang JY; Wang YQ; Wang HX; Bao XF; Meng GL
Int J Mol Sci; 2018 Aug; 19(9):. PubMed ID: 30200365
[TBL] [Abstract][Full Text] [Related]
10. The SIRT3-ATAD3A axis regulates MAM dynamics and mitochondrial calcium homeostasis in cardiac hypertrophy.
Li Z; Hu O; Xu S; Lin C; Yu W; Ma D; Lu J; Liu P
Int J Biol Sci; 2024; 20(3):831-847. PubMed ID: 38250153
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial deacetylase Sirt3 in vascular dysfunction and hypertension.
Dikalov S; Dikalova A
Curr Opin Nephrol Hypertens; 2022 Mar; 31(2):151-156. PubMed ID: 35086984
[TBL] [Abstract][Full Text] [Related]
12. SIRT3-dependent mitochondrial redox homeostasis mitigates CHK1 inhibition combined with gemcitabine treatment induced cardiotoxicity in hiPSC-CMs and mice.
Chen JW; Shan TK; Wei TW; Jiang QQ; Du C; Gu LF; Yang TT; Zhou LH; Wang SB; Bao YL; Wang H; Ji Y; Xie LP; Gu AH; Sun CQ; Wang QM; Wang LS
Arch Toxicol; 2023 Dec; 97(12):3209-3226. PubMed ID: 37798514
[TBL] [Abstract][Full Text] [Related]
13. The loss of cardiac SIRT3 decreases metabolic flexibility and proteostasis in an age-dependent manner.
Li P; Newhardt MF; Matsuzaki S; Eyster C; Pranay A; Peelor FF; Batushansky A; Kinter C; Subramani K; Subrahmanian S; Ahamed J; Yu P; Kinter M; Miller BF; Humphries KM
Geroscience; 2023 Apr; 45(2):983-999. PubMed ID: 36460774
[TBL] [Abstract][Full Text] [Related]
14. Roles of SIRT3 in heart failure: from bench to bedside.
Hu DX; Liu XB; Song WC; Wang JA
J Zhejiang Univ Sci B; 2016 Nov.; 17(11):821-830. PubMed ID: 27819129
[TBL] [Abstract][Full Text] [Related]
15. Sodium-glucose exchanger 2 inhibitor canagliflozin promotes mitochondrial metabolism and alleviates salt-induced cardiac hypertrophy via preserving SIRT3 expression.
Zhao Y; Lu Z; Zhang H; Wang L; Sun F; Li Q; Cao T; Wang B; Ma H; You M; Zhou Q; Wei X; Li L; Liao Y; Yan Z; Liu D; Gao P; Zhu Z
J Adv Res; 2024 May; ():. PubMed ID: 38744404
[TBL] [Abstract][Full Text] [Related]
16. Emodin Inhibited Pathological Cardiac Hypertrophy in Response to Angiotensin-Induced Hypertension and Altered the Gut Microbiome.
Evans L; Price T; Hubert N; Moore J; Shen Y; Athukorala M; Frese S; Martinez-Guryn K; Ferguson BS
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759673
[TBL] [Abstract][Full Text] [Related]
17. Sinapic Acid Inhibits Cardiac Hypertrophy via Activation of Mitochondrial Sirt3/SOD2 Signaling in Neonatal Rat Cardiomyocytes.
Yun UJ; Yang DK
Antioxidants (Basel); 2020 Nov; 9(11):. PubMed ID: 33233476
[TBL] [Abstract][Full Text] [Related]
18. Advances in the pharmacological effects and molecular mechanisms of emodin in the treatment of metabolic diseases.
Yu L; Zhao Y; Zhao Y
Front Pharmacol; 2023; 14():1240820. PubMed ID: 38027005
[No Abstract] [Full Text] [Related]
19. Ultrasound-assisted extraction of emodin from Rheum officinale Baill and its antibacterial mechanism against Streptococcus suis based on CcpA.
Bai J; Xie Y; Li M; Huang X; Guo Y; Sun J; Tang Y; Liu X; Wei C; Li J; Yang Y
Ultrason Sonochem; 2024 Jan; 102():106733. PubMed ID: 38150957
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of rhubarb in the treatment of hyperlipidemia: A recent review.
Wu L; Wang X; Jiang J; Chen Y; Peng B; Jin W
Open Med (Wars); 2023; 18(1):20230812. PubMed ID: 37808167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
